BCBS North Carolina Medical Policy Updates – October 2018

Click here to view the Blue Cross Blue Shield North Carolina Medical Policy Updates »

October 2018 Medical Policy Updates:

• Ado-Trastuzumab Emtansine (Trastuzumab-DM1) for Treatment of HER-2 Positive Malignancies
• Ambulance and Medical Transport Services
• Bone Mineral Density Studies
• Buprenorphine Implant for Treatment of Opioid Dependence
• CAR-T Therapy
• Cellular Immunotherapy for Prostate Cancer
• Children’s Mobility and Positioning Equipment
• Chiropractic Services
• Corneal Collagen Cross-linking
• Cryosurgical Ablation of Miscellaneous Solid Tumors Other Than Liver, Prostate, or Dermatologic Tumors
• Cryosurgical Ablation of Primary or Metastatic Liver Tumors
• Denosumab (Prolia™, XGEVA™)
• Dry Needling of Myofascial Trigger Points
• Durable Medical Equipment (DME)
• Eculizumab (Soliris®)
• Enzyme Replacement Therapy (ERT) for Lysosomal Storage Disorders
• Extracorporeal Shock Wave Treatment for Musculoskeletal Conditions and Wound Healing
• Functional Capacity Assessment and Work Hardening
• General Approach to Genetic Testing
• Goserelin Acetate (Zoladex)
• Infertility Diagnosis and Treatment
• Injectable Bulking Agents for the Treatment of Urinary and Fecal Incontinence
• Keratoprosthesis
• Laparoscopic and Percutaneous Techniques for the Myolysis of Uterine Fibroids
• Liver Transplant and Combined Liver Kidney Transplant
• Lumbar Spine Fusion Surgery
• Multitarget Polymerase Chain Reaction Testing for Diagnosis of Bacterial Vaginosis
• Necitumumab (Portrazza)
• Noninvasive Fetal RHD Genotyping Using Cell-Free Fetal DNA
• Noninvasive Prenatal Testing for Fetal Aneuploidies Using Cell-Free Fetal DNA
• Orthotics
• Patient Lifts
• PD-1 Inhibitors
• PD-L1 Inhibitors
• Pelvic Floor Stimulation as a Treatment of Urinary and Fecal Incontinence
• Pharmacogenetic Testing for Drug Metabolism
• Pressure Reducing Support Surfaces
• Radiofrequency Ablation of the Renal Nerves as a Treatment of Hypertension
• Rehabilitative Therapies
• Respiratory Syncytial Virus Prophylaxis
• Sleep Apnea: Diagnosis and Medical Management
• Speech Generating Devices
• Talimogene Laherparepvec (Imlygic™)
• Testosterone Pellet Implantation for Androgen Deficiency
• Topotecan Hydrochloride (Hycamtin)
• Transtympanic Micropressure Applications as a Treatment of Meniere’s Disease
• Trastuzumab
• Wheelchairs (Manual and Power Operated)
• White Blood Cell Growth Factors

Click here to view the Blue Cross Blue Shield North Carolina Medical Policy Updates »

Policy Alerts monitors Commercial and Medicare medical policies for changes. While medical Insurance carriers typically update medical policies annually, there are many reasons why they might review or update a policy. When reviews occur out of cycle they often go unnoticed. Policy Alerts keeps you updated when Payers make coverage changes to medical policies affecting your business.

Policy Alerts continuously monitors Commercial and Medicare Payer coverage information to keep you up-to-date on medical Insurance decisions in real-time. When changes occur, instant email alerts are delivered to your inbox. Clients have access to detailed coverage reports and medical policies through the interactive Policy Alerts Dashboard portal. Save time each month and keep focused on important Payer medical policy reviews and coverage decisions affecting your business!

Policy Alerts takes a client-focused hands-on approach and is constantly working to provide our customers with helpful insights and actionable analytics. We understand what our clients need and are dedicated to providing timely, accurate, and always up-to-date reports.

Health economic and reimbursement information provided by Policy Alerts is gathered from third-party sources and is subject to change without notice as a result of complex and frequently changing laws, regulations, rules and policies. All product and company names are trademarks™ or registered® trademarks of their respective holders. Use of them does not imply any affiliation with or endorsement by them. This information is presented for illustrative purposes only and does not constitute reimbursement or legal advice.